Table 2.
Regimens | Antiangiogenic group | Control Group | P Value | ||
---|---|---|---|---|---|
Number | ProgressN (%) | Number | ProgressN (%) | ||
AP | 7 | 0 (0) | 17 | 3 (17.7) | |
GP | 9 | 0 (0) | 10 | 2 (20) | |
TP | 2 | (0) | 2 | 0 (0) | |
PEM | 4 | 0 (0) | 1 | 1 (100) | |
All | 22 | 0 (0) | 30 | 6 (20) | 0.033 |
Including PEM scheme | 11 | 0 (0) | 18 | 4 (22.2) | 0.268 |
AP, pemetrexed+cisplatin; GP, gemcitabine+cisplatin; TP, nano albumin paclitaxel+platinum; PEM, pemetrexed.